| Date | Time | Source | Headline | Symbol | Company |
| 11/09/2011 | 4:10AM | Zacks | Company News for November 9, 2011 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/08/2011 | 6:41AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/08/2011 | 6:30AM | PR Newswire (US) | Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/02/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the Credit Suisse 2011 Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/02/2011 | 8:16AM | Marketwired | Optimism on Diabetes Medication Grows -- MannKind and Amylin Benefit | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/28/2011 | 4:49PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/21/2011 | 10:08AM | Zacks | Amylin Posts Lower Loss - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/20/2011 | 6:02AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2011 | 6:10PM | PR Newswire (US) | BYETTA® Approved for Use with Insulin Glargine in the U.S. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2011 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2011 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/18/2011 | 4:39AM | Dow Jones News | UK Body Recommends Lilly, Amylin Diabetes Drug Bydureon | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/14/2011 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/14/2011 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/14/2011 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/12/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/11/2011 | 10:45AM | Zacks | Alkermes Upped to Outperform - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2011 | 5:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/22/2011 | 4:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/15/2011 | 1:20PM | Dow Jones News | Icahn Firm's Denner Might Leave To Start Hedge Fund -Bloomberg | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/15/2011 | 5:45AM | Zacks | Novo Nordisk's Data at EASD - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/13/2011 | 11:00AM | Zacks | Data Announced on Bydureon - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/12/2011 | 7:10AM | Business Wire | Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/12/2011 | 7:00AM | PR Newswire (US) | Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/07/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/31/2011 | 9:00AM | Zacks | Risk Reward Balances Alkermes - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/30/2011 | 11:18AM | Zacks | EU Approval for Lilly's Trajenta - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/19/2011 | 6:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/17/2011 | 4:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/11/2011 | 12:42PM | Zacks | FDA Action Date for Amylin's Bydureon - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |